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Abstract
Background: There are recent experimental reports on the cross-regulation between molecules involved in the
control of the cell cycle and the differentiation of the vulval precursor cells (VPCs) of Caenorhabditis elegans. Such
discoveries provide novel clues on how the molecular mechanisms involved in the cell cycle and cell differentiation
processes are coordinated during vulval development. Dynamic computational models are helpful to understand the
integrated regulatory mechanisms affecting these cellular processes.
Results: Here we propose a simplified model of the regulatory network that includes sufficient molecules involved in
the control of both the cell cycle and cell differentiation in the C. elegans vulva to recover their dynamic behavior. We
first infer both the topology and the update rules of the cell cycle module from an expected time series. Next, we use
a symbolic algorithmic approach to find which interactions must be included in the regulatory network. Finally, we
use a continuous-time version of the update rules for the cell cycle module to validate the cyclic behavior of the
network, as well as to rule out the presence of potential artifacts due to the synchronous updating of the discrete
model. We analyze the dynamical behavior of the model for the wild type and several mutants, finding that most of
the results are consistent with published experimental results.
Conclusions: Our model shows that the regulation of Notch signaling by the cell cycle preserves the potential of the
VPCs and the three vulval fates to differentiate and de-differentiate, allowing them to remain completely responsive
to the concentration of LIN-3 and lateral signal in the extracellular microenvironment.
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Background
The nematode Caenorhabditis elegans has been exten-
sively used as a model organism in research areas such
as genetics, genomics, cellular signaling cascades, neuro-
science, aging, developmental biology, and cell differenti-
ation [1-4]. C. elegans is specially suitable for the study of
cell differentiation because its cell lineagemap is both fully
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characterized and almost invariant [5,6]. In particular, the
vulva of C. elegans has been used as an experimental
model for the study of organ formation, cellular fusion,
and intracellular signaling [7-11].
The vulva has two main biological functions, namely,
copulation and egg laying. This organ is formed by seven
epithelial rings connecting the uterus with the ventral
hypodermis, forming a path from the interior of the
uterus to the external environment. This path is closed
to keep pathogens out of the worm, except when the
vulval muscles open it to perform its functions. Each
ring of the vulva is formed by cells of a different kind,
namely (in ventral-to-dorsal order): vulA, vulB1, vulB2,
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vulC, vulD, vulE, and vulF, containing a total of 22 nuclei
(Figure 1). In the adult, most of these rings are formed
by a single tetranucleated syncytium, the exceptions being
Figure 1 Formation and specialization of the vulval cells during
the first hours of development of C. elegans. Larval phase L1: 0 h)
After eclosion, the worm has two rows of P cells in the middle ventral
region. 10 h) The rows merge. Larval phase L2: 12 h) The cells P1-P12
undergo a longitudinal division, the anchor cell forms (brown oval),
and P3.p-P8.p become vulval precursor cells (VPCs). 25 h) P6.p
responds to LIN-3/EGF secreted by the AC and acquires the primary
fate (red), this cell secrets the DSL ligands that constitute the lateral
signal. 28 h) P5.p and P7.p respond to the lateral signal of P6.p, thus
acquiring the secondary fate (yellow). The rest of the VPCs acquire the
tertiary fate forming the pattern 3rd3rd2nd1st2nd3rd . Larval phase L3:
30 h) Cells P3.p to P8.p divide longitudinally, and the daughters of the
secondary fate cells are polarized. 32 h) The descendants of the tertiary
fate cells fuse with hyp7 and the rest divide longitudinally once more,
and the most proximal granddaughters of P6.p are induced again by
the anchor cell (AC). Larval phase L4: 36 h) Formation of the adult
vulval cells: some descendants of the VPCs divide a third time with
the pattern LLTN TTTT NTLL. L stands for a lateral division, forming
anterior and posterior daughters. T is a transverse division, forming
left and right daughters. N stands for no division. Cells are classified, in
proximal to distal order as vulF (red), vulE (orange red), vulD (orange),
vulC (yellow), vulB2 and vulB1 (green yellow), and vulA (green).
the binucleated syncytium ring vulD, as well as the vulB1
and vulB2 rings that contain two half-ring binucleated
syncytia each [6].
The cellular and molecular mechanisms controlling the
development of the vulva have been experimentally stud-
ied for more than three decades by means of cell ablations
[12-14], mutations causing some specific vulval pheno-
types [15-18], or mutations that rescue vulval pheno-
types [19-24]. Furthermore, the roles of the Ras/MAPK,
Fgf, Notch, and Wnt signaling cascades during the
formation of the vulva have been extensively studied
[11,25-27].
The first stage of vulval development is the formation
of the vulval competence group. The nematode is born
with two rows of P cells containing six cells each (Figure 1,
0h); these cells migrate towards the ventral mid-line form-
ing one row (Figure 1, 10 h). The P cells then undergo a
longitudinal division; the anterior daughter cells acquire
neuronal fates, while the posterior daughter cells acquire
hypodermal fates. Six of the posterior daughters, namely
P3.p, P4.p, P5.p, P6.p, P7.p, and P8.p (Figure 1, 12 h), are
induced by Wnt and Ras signaling to become the vulval
competence group [28-30].
The second stage of the process is defined by the dif-
ferentiation and proliferation, instead of the formation of
vulval cells. It is known that the fate of VPCs (Figure 1,
25 h and 28 h) is determined by the induction from
the anchor cell (AC, a gonadal cell located dorsally with
respect to the cell P6.p), the lateral signaling among the
VPCs, and the concentration of Wnt ligands secreted by
the AC as well as cells near the tail. The VPCs may acquire
one of three fates, P6.p acquires the primary fate that is
characterized by the expression of egl-17, lin-39, apx-1,
and dsl-1 as well as the transverse division of its grand-
daughters. P5.p and P7.p acquire the secondary fate that is
characterized by the expression of lin-11 and lip-1 and the
diverse planes of division of its granddaughters. Specifi-
cally, the most proximal granddaughters do not divide, the
next most proximal granddaughters divide transversely,
and the two most distal granddaughters divide longitudi-
nally. P3.p, P4.p, and P8.p acquire the tertiary fate, tertiary
fate VPCs divide longitudinally once, and their daughters
fuse with hyp7. Then, the VPCs divide longitudinally once
and the cells that acquired the tertiary fate fuse with the
ventral hypoderm. Also, the daughters of the secondary
fate cells are polarized byWnt signaling (Figure 1, 30 h). At
this point the six remaining VPC daughters undergo a sec-
ond longitudinal division (Figure 1, 32 h). Finally, most of
the granddaughters of the VPCs divide a third time, except
for the most proximal descendants of the secondary fate
cells.
The third stage of the process is morphogenesis and
determination of the final fates of vulval cells. The vul-
val cells migrate towards the AC, and then they fuse
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forming the seven rings that give the adult vulva its final
shape. During this stage the AC breaks the membrane
that separates the gonad from the epidermis, connecting
both tissues and opening the vulval channel. The devel-
oping vulva directs the growth and attachment of the
vulval muscles [6-8,11], and the adult fates of the vulval
cells are determined. Remarkably, there is scarce infor-
mation regarding the molecular network that controls
this third stage of the cell differentiation in the vulva
[11,31].
The cell cycle and fate determination in C. elegans are
synchronized due to the interconnection of the molec-
ular mechanisms controlling both processes, which is
described in detail as part of the molecular basis of
the regulatory network. Additionally, the heterochronic
genes lin-4, lin-14, and lin-28 are important for the
control of developmental timing. In the vulva, LIN-14
activity is required during L1, LIN-28 activity is nec-
essary during L2 and early L3 to prevent premature
vulval cell divisions, and lin-4 activity is required dur-
ing L3 for the cellular divisions that occur during this
stage, and the proper determination of the secondary fate
[11,32,33].
There are several models describing the process of cell
specialization in the vulva of C. elegans [34]. The first
models were diagrammatic and static [14,35], describing
how the inductive and lateral signals interact to deter-
mine the fates of the VPCs. Later models emphasized the
importance of the concentration of the inductive and lat-
eral signals, producing bi-dimensional fate maps [36-38],
and epigenetic landscapes [39]. Some models were devel-
oped with a focus on the importance of the order in the
sequence of signals [40-42], others incorporated an evo-
lutionary perspective [37,38], and still others were built
to test new methodologies or tools for the simulation
of molecular network models [43-47]. Recently, we pro-
posed a dynamic regulatory network model to include the
molecules that are involved in the control of cell fusion
and cell polarization during the first stages of vulva devel-
opment. Such a model included the Wnt, Ras, and Notch
signaling pathways, as well as the interactions among
them, and the relevant Hox genes [30].
The cell cycle has been extensively studied in several
species, and as a result there is a large number of mathe-
matical and computational models for eukaryotes in gen-
eral [48-51], mammals [52,53], and also for several specific
model systems, including fission yeast [54-58], budding
yeast [59-61], amphibian embryos [62,63], A. thaliana
([64], Ortiz-Gutiérrez et al. in preparation), and notably
the embryonic cell cycle of C. elegans [65]. Many dis-
crete and continuous dynamical models have been used
to find the molecular interactions that are necessary and
sufficient to recover the observed cyclic behavior of sev-
eral cell cycle regulators. Some models have focused on
the cell cycle checkpoints [54,55,62], or have analyzed the
role of cell mass during cell cycle progression [55,58,59].
While most of the previous models were built with the use
of ordinary differential equations [48,49,53,56,58], there
are also examples of hybrid [52] and discrete models
[60,61,65,66].
Despite the abundance of models developed for VPC
fate determination and cell cycle dynamics in other organ-
isms and the C. elegans embryo, the effect of coordi-
nation of the cell cycle and cell differentiation during
vulval development has not been fully explored. Hereby
we present the first model to include the molecular mech-
anism involved in the control of the postembryonic cell
cycle of C. elegans. Dynamical models are important to
understand how the molecular components involved in
these cellular processes are integrated to coordinate the
differentiation and proliferation during VPC fate speci-
fication. Such an integrative model is the focus of this
paper. Our main findings are that the regulation of Notch
signaling by the cell cycle preserves the potential of the
VPCs and the three vulval fates to differentiate and de-
differentiate, and that sequential control does not elim-
inate the sensitivity of the VPCs to inductive or lateral
signaling during VPC fate determination.
Results and discussion
The regulatory network
The regulatory network consists of 14 nodes and 37 reg-
ulatory interactions (Figure 2). The network incorporates
regulatory interactions experimentally substantiated in C.
elegans, five interactions documented in other organisms,
and six interactions that constitute novel predictions from
the present study. All such predictions, with the exception
of the inhibition of CDK-1/CYB-3 by CKI-1, are neces-
sary to recover the observed attractors. The exhaustive
analysis of the dynamical behavior of the network as a
discrete dynamical system revealed the existence of eight
periodic attractors that cycle through the same stages of
the cell cycle (Figure 3), partitioning evenly the state space
(Figure 4).
The eight attractors can be interpreted as the patterns
of molecular activation of the three vulval fates that cycle
through the cell cycle (Figures 3 and 4). Attractors A, B,
and C represent the primary fate, which is characterized
by a high level (2 in our model) of LIN-39 and MPK-
1 activity. Attractors D, E, F and G correspond to the
secondary vulval fate which is characterized by LIN-12i
activity. Notably, in all these attractors, LIN-12i is inac-
tive during the first and last states of the cycle, due to
the inhibitory effect of CDK-1/CYB-3. Finally, the tertiary
fate is represented exclusively by attractor H, which is
characterized by a low level of activity of LIN-39, and no
LIN-12i, LIN-3, or lateral signal (LS) activity. This pattern
of expression is observed in the VPCs during L2.
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Figure 2 The network of molecules involved in the control of VPC fate determination and the cell cycle in C. elegans. Pointed arrows are
positive regulatory interactions, and blunt arrows are negative regulatory interactions. Purple arrows are interactions reported in other organisms,
and green arrows are predictions of our model. Orange nodes are part of the Notch pathway, and blue nodes are part of the Ras/MAPK pathway or
its targets (LIN-39). Green nodes are CDK/Cyclin complexes, yellow nodes are CDK inhibitors, EFL-1, a transcription factor in white, and protein
degradation complexes in gray. The external signals are represented as elongated hexagons, the known transcription factors as ellipses, and other
proteins as rounded rectangles.
Dynamics of the cell cycle module
Figure 3 shows the dynamical behavior of the regula-
tory network. The model recovers eight cyclic attractors,
corresponding to the observed patterns of expression in
actual cells. For example, Figure 3H shows the cyclic
attractor that corresponds to tertiary fate cells and VPCs.
At the beginning (G1-1), the inhibitors of the cell cycle,
CKI-1, LIN-35, and the APC complex, are active. Then,
APC is turned off, which leads to CKI-1 inactivation
(G1-3), and thus allowing the CDK-4/CYD-1 complex to
become active (G1-4), which is a marker for G1 progres-
sion. Next, the LIN-35 activity is inhibited (G1-5), leading
to EFL-1 activation (G1-6) first, and then the CDK-
2/CYE-1 complex, a marker of the S phase (S1). Later, the
SCF turns on (S2), leading to the G2 phase where only
EFL-1 and SCF are active (G2). Further on, LIN-35, and
the CDK-1/CYB-3 complex, which is a marker for the M
phase, are activated (M1). Leading to the EFL-1 inhibition
and APC activation (M2). Finally, the activity of CDK-
1/CYB-3 is inhibited, leading back to the beginning of G1
(G1-1).
Figures 3E, 3F and 3G show attractors that describe the
behavior of most secondary fate cells, the cell cycle in sec-
ondary fate cells is one step shorter because the G1 phase
lasts for only 5 time steps. Figure 3D, which describes the
cyclic behavior of a secondary fate cell in a microenviron-
ment with a high level of LIN-3 (2 in our model), as well as
Figures 3A-C that describe the cyclic behavior of primary
fate cells, share the same cyclic behavior as secondary and
tertiary fate cells, except for the fact that their G1 phase
lasts for only 4 steps.
By modeling the cell cycle module on its own, it is pos-
sible to observe that the cyclic behavior described above
covers its entire state space (Figure 5A). Observe that the
cyclic behavior of this module is maintained when it is
modeled as a continuous dynamic system (Figure 5B), thus
reducing the possibility of the cyclic behavior being an
artifact of the modeling framework.
The differentiation process
To study the process of fate determination in our model,
we followed the dynamics of the system starting from the
initial patterns of expression that represent the different
cell fates under different extracellular microenvironments
(Figures 4 and 6). First, we followed the determination of
the primary fate, which occurs when the concentration
of LIN-3 is very high (3 in our model), with (Figure 7-3)
or without (Figure 7-2) an active LS, or when the con-
centration of LIN-3 is moderately high (2 in our model)
and the concentration of LS is lower than the threshold
(0 in our model) (Figure 7-1). We also followed the net-
work with an initial state representing a secondary fate
cell under a microenvironment which induces a VPC to
acquire the primary fate. In this case the network reaches
a cyclic pattern of molecular activation that corresponds
to the primary fate (Figure 7-4). Then, we followed the
determination of the secondary fate, which may occur
when a VPC or a primary fate cell is in the following
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Figure 3 The attractors of our model. There is a total of eight cyclic attractors, with time running from left to right. Activity of LIN-12i, in orange, is
a marker of the secondary fate (Attractors D, E, F and G). A high level of activity (2 in our model) of LIN-39, in dark blue, is a marker for the primary
fate (Attractors A, B, and C). The tertiary fate is represented exclusively by attractor H, which is characterized by a low level of activity of LIN-39, and
no LIN-12i, LIN-3, or lateral signal (LS) activity (This pattern of expression is observed in the VPCs during L2). CDK-4/CYD-1, shown in pale green, is
activated before the S phase. CDK-2/CYE-1, shown in green, is a marker of the S phase. CDK-1/CYB-3, in dark green, is a marker for the M phase.
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Figure 4 Summary of the basins of attraction. The stars in each basin represent all possible activity levels for the molecule. The primary fate
basins are colored in blue, the secondary fate basins in orange, the tertiary fate basin in green and the fusion fate basin in gray. Loss of WNT activity
was simulated by changing the basal state of LIN-39 from 1 to 0.
microenvironments: LS and no LIN-3 activity (0 in our
model)(Figure 8-1), low LIN-3 (1 in our model) with no
LS (Figure 8-2), LS and low LIN-3 (Figure 8-3), or LS and
medium high LIN-3 (Figure 8-4 and 8-5). Last, we fol-
lowed the determination of the tertiary fate which may
occur when a VPC/Tertiary-fate cell (Figure 9-1), a sec-
ondary fate cell (Figure 9-2) or a primary fate cell(Figure 9-
3), is in a microenvironment with no LS and no LIN-3 (0
in our model).
Our model shows that the cell fates remain stable if the
extracellular microenvironment remains stable, but the
cells keep the potential to acquire any other fate if the
microenvironment changes. Specifically, a primary or sec-
ondary fate cell has the potential to de-differentiate in
a microenvironment without both LIN-3 and LS, a pri-
mary fate cell may trans-differentiate into a secondary fate
cell in a microenvironment with low LIN-3 or LS and a
secondary fate cell may also trans-differentiate into a pri-
mary fate cell in a microenvironment with moderately
high LIN-3 and no LS or very high LIN-3 (Figures 4 and
6). Both de-differentiation and trans-differentiation have
been observed experimentally [67].
Finally, it is important to note that the influence of the
differentiation process over the cell cycle module has an
effect on the length of the periodic behavior (Figure 3).
Specifically, G1 lasts 4 time steps for the primary fate, 4
to 6 time steps for the secondary fate, and 6 time steps
for the tertiary fate. This behavior arises because the Ras
signaling shortens the duration of the cell cycle by inhibit-
ing CKI-1. Specifically, when Ras signaling is moderate
(Figure 3E-F), the cell cycle lasts ten time steps. But when
the level of Ras signaling is high (Figure 3A-D), CKI-1 is
not activated and thus the cell cycle lasts 9 time steps. The
duration of the cell cycle may determine the number of
times the VPCs divide, because the period of time when
the VPCs may divide is limited.
Simulation of mutants
One way to validate the type of regulatory network model
presented here, is to test if altered expression states of
the model components lead to altered attractors that
mimic the observed patterns of expression and/or phe-
notypes described for loss and gain of function mutants.
We simulated the effect of all 32 possible single loss-
and gain-of-function mutations by setting the expres-
sion level of the corresponding node to zero, one, two,
or three. We obtained the attractors of all these mutant
models and compared them against the available experi-
mental data (Additional file 1: Table S1, Additional file 2).
Notably, 16 of the 18 phenotypes reported in the liter-
ature (88.9%) are recovered by these simulations. The
simulated phenotypes caused by 24 mutations can be
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Figure 5 Dynamics of the cell cycle. A) State space of our Boolean module. Color-coded transition diagram of the cell cycle: the red component
represents the activity of CKI-1, EFL-1 and LIN-35, the green component represents the activity of SCF and APC, and the blue component represents
the activity of CDK-4/CYD-1, CDK-2/CYE-1 and CDK-1/CYB-3. B) Dynamics of our continuous model of the cell cycle. The initial state for the
numerical integration starts at the first stage of G1.
considered novel predictions of our model; of those 24
simulatedmutations the effect of 14 has not been reported
at all in the literature, and the other 10 cause additional
effects in specific extracellular microenvironments that
have not been observed experimentally. Specifically, our
model predicts that a) a constitutively active lateral signal
will prevent the determination of the tertiary fate, b)mpk-
1(1) will cause the loss of the primary fate, c) mpk-1(2)
will cause the loss of the secondary fate, d) five muta-
tions will cause the VPCs to exit the cell cycle, e) two
mutations will cause endoreplication, f ) 15 mutations will
allow the determination of the secondary fate in an extra-
cellular microenvironment with a medium level of LIN-3
and no LS, g) nine mutations will allow the determination
of the primary fate in an extracellular microenvironment
with a medium level of LIN-3 and LS, h) 15 mutations
will allow the determination of the secondary fate in an
extracellular microenvironment with no LIN-3 and no LS,
i) two mutations allow the determination of the tertiary
fate in an extracellular microenvironment with LS and no
LIN-3, j) according to our model, lin-39(2) represents a
high concentration of constitutively phosphorylated LIN-
39 and the result of its simulation is a Muv phenotype
where all VPCs acquire the primary fate. Experimentally,
the expression of heat shock-inducible lin-39 after the
ablation of the anchor cell during L2 was not enough to
allow the VPCs to divide, and a high level of LIN-39 pro-
tein does not cause a Muv phenotype. But that might be
because LIN-39 needs to be phosphorylated by MPK-1
in order to be activated [68], in order to prove or refute
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Figure 6 The process of the cell differentiation. Colored triangles represent the different cellular fates. The different signals that are able to move
the model from one fate to another are specified on the table at the bottom of the figure, and the primary fate basins are colored in blue, the
secondary fate basins in orange, the tertiary fate basin in green and the fusion fate basin in gray.
our prediction, the same experiment would need to be
repeated, but with a constitutively phosphorylated LIN-
39, k) according to our model, lin-12i(0) represents the
loss of the transcription factor function of lin-12 locally
in the VPCs that causes the loss of secondary fate VPCs,
but not necessarily the Muv phenotype reported in the lit-
erature where lin-12(lf ) causes two anchor cells to form,
causing a Muv and Egl phenotype where most VPCs
acquire the primary fate [35], in order to verify this pre-
diction the extra AC needs to be ablated in a lin-12(lf )
and lip-1::GFP background to verify that the secondary
fate is lost but the VPCs may still acquire the primary and
tertiary fates, l) According to our model, lin-12m(0) rep-
resents the loss of LIN-12 protein in the membrane that
produces a wild type phenotype, because we assume that
Notch may still be activated internally by weak Ras signal-
ing [27]. We remark that two of our simulated mutants,
namely efl-1(0), and SCF(0), do not have a clear corre-
spondence with the experimental results.
The loss of efl-1 function has been reported to cause
a phenotype that resembles the phenotype caused by
lin-35(lf ), suggesting that it is a G1/S inhibitor. Conversely,
its co-factor dpl-1 has been reported to both activate and
inhibit the G1/S transition [69]. However, according to our
model, EFL-1/DPL-1 functions as a transcriptional activa-
tor, as reported for the yeast and mammalian cell cycles
[70], while efl-1(0) causes the cell cycle to stop between
G1 and S.
Finally, according to our model, SCF(0) causes the cell
cycle to stop at the S phase. However, the function of
SCF is necessary for the cell cycle exit. cul-1 is one of the
main components of SCF, and cul-1(lf ) causes very strong
hyperplasia in the vulva, and more than 80 vulval cells are
formed in those mutants [71]. SCF complexes have many
diverse functions and only a few are well characterized.
Specifically, SCF is necessary for CDC-25.1 degradation,
whichmay be necessary for cell cycle quiescence [72]. Fur-
thermore, negative regulation of CDK/Cyclin complexes
is an important component even in minimal cell cycle
oscillators [63]. Due to the simplified nature of our model,
the function of SCF as a G1/S CDK/Cyclin regulator is
crucial for cell cycle progression, but in the real system
other complexes such as APC may act redundantly with
SCF.
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Figure 7 Primary fate determination. 1) A VPC differentiating into a primary fate cell in an extracellular microenvironment with a moderately high
concentration of LIN-3 (2 in our model), 2) A VPC differentiating into a primary fate cell in an extracellular microenvironment with a high
concentration of LIN-3 (3 in our model), 3) A VPC differentiating into a primary fate cell in an extracellular microenvironment with lateral signal and a
high concentration of LIN-3 (3 in our model), 4) A secondary fate cell transdifferentiating into a primary fate cell in an extracellular
microenvironment with a high concentration of LIN-3 (3 in our model).
Removal of regulatory interactions
We systematically eliminated all of the 38 regulatory inter-
actions, one at the time, and evaluated the effect on
the attractors attained by the model (Additional file 3:
Table S2, Additional file 4). Notice that the removal of
12 interactions had no effect on the dynamics of the
network, thus showing the structural robustness of the
model.
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Figure 8 Secondary fate determination. 1) A VPC differentiating into a secondary fate cell in an extracellular microenvironment with lateral
signal, 2) A VPC differentiating into a secondary fate cell in an extracellular microenvironment with a low concentration of LIN-3 (1 in our model),
3) A VPC differentiating into a secondary fate cell in an extracellular microenvironment with lateral signal and a low concentration of LIN-3, 4) A VPC
differentiating into a secondary fate cell in an extracellular microenvironment with lateral signal and a moderately high (2 in our model)
concentration of LIN-3, 5) A primary fate cell transdifferentiating into a secondary fate cell in an extracellular microenvironment with a moderately
high concentration of LIN-3 (2 in our model) and lateral signal.
There is a discrepancy between our model and the
reported experimental results regarding the removal of
the activation of LIN-12i by CDK-2/CYE-1. In the model,
the elimination of this interaction has no effect on the
dynamics of the network. Experimentally, however, the
elimination of the aforementioned interaction causes a
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Figure 9 Tertiary fate determination. 1) The tertiary fate is stable in an extracellular microenvironment without LS or LIN-3, 2) A secondary fate
cell dedifferentiating into a third fate cell in an extracellular microenvironment without LS or LIN-3, 3) A primary fate cell dedifferentiating into a
third fate cell in an extracellular microenvironment without LS or LIN-3.
diminished concentration of LIN-12i in secondary fate
cells [42]. Given the Boolean nature of the variable rep-
resenting LIN-12i, the model cannot represent a partial
reduction on its activation. Future versions on our model
will, by necessity, incorporate more levels of activation to
describe LIN-12i.
We predict the effect of removing 28 interactions that
are not reported in the literature. Specifically, our model
predicts that a) removing one of eight interactions would
not affect the behavior of the system, b) removing the
ability of MPK-1 to phosphorylate LIN-39 will cause the
loss of the primary fate, c) removing one of four interac-
tions would inhibit VPC divisions, d) removing one of two
interactions, will lead to an endoreplication cell cycle, e)
removing one of four interactions would cause a longer
cell cycle, f ) removing one of eight interactions causes
a shorter cell cycle, g) removing one of seven interac-
tions will allow the determination of the secondary fate
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in an extracellular microenvironment with no LIN-3 and
no LS, h) removing one of ten interactions will allow the
determination of the secondary fate in an extracellular
microenvironment with a medium level of LIN-3 and no
LS, and j) removing one of four interactions will allow
the determination of the primary fate in an extracellular
microenvironment with a medium level of LIN-3 and LS.
We then searched for the interactions that are necessary
for the existence of the cyclic attractor. The update rules
of our model of the cell cycle module (Equations 7-14) are
not ambiguous. Without allowing ambiguity in the update
rules, we found with Griffin a [73] 120 functional network
topologies of the cell cycle module that allow the exis-
tence of the cyclic attractor. All such topologies include
the following 14 interactions: a) the inhibition of EFL-1 by
LIN-35, b) the activation of APC by CDK-1/CYB-3, c) the
inhibition of LIN-35 by CDK-4/CYD-1, d) the activation
of SCF by CDK-2/CYE-1, e) the inhibition of CDK-2/CYE-
1 by SCF, f ) the inhibition of CDK-4/CYD-1 by SCF, g) the
inhibition of CDK-2/CYE-1 by LIN-35, h) the activation of
CDK-1/CYB-3 by EFL-1, i) the inhibition of CDK-4/CYD-
1 by CKI-1, j) the activation of CKI-1 by APC, k) the
activation of CKI-1 by CDK-1/CYB-3, l) the inhibition
of CDK-1/CYB-3 by CDK-4/CYD-1, m) the inhibition of
CDK-4/CYD-1 by CDK-1/CYB-3, and n) the activation of
CDK-2/CYE-1 by EFL-1.
We performed an additional test to check which inter-
action signs may be ambiguous by including all the
interactions of our original model. Allowing ambiguity
resulted in 2740 functional network topologies. However,
in order for the cyclic attractor to exist, the following eight
interaction signs must not be ambiguous: a) the inhibi-
tion of EFL-1 by LIN-35, b) the inhibition of CKI-1 by
CDK-4/CYD-1, c) the inhibition of APC by SCF, d) the
inhibition of SCF by APC, e) the activation of SCF by
CDK-2/CYE-1, f ) the activation of APC by CDK-1/CYB-
3, g) the inhibition of LIN-35 by CDK-4/CYD-1, and h) the
inhibition of LIN-35 by CDK-2/CYE-1.
Circuits
Circuits or feedback loops are circular chains of interac-
tions. The present model contains 60 positive feedback
loops, and 51 negative feedback loops (Tables 1 and 2).
The work of Thomas and collaborators has demonstrated
the central role of feedback loops in the determination of
the dynamic behavior of a regulatory network [74]. Specif-
ically, functional positive feedback loops are necessary for
the existence of multistationarity, while negative feedback
loops are necessary to obtain oscillations [75].
According to our model, there is large redundancy
among circuits, and thus no single circuit can be con-
sidered essential for the determination vulval fates. By
contrast, the specific combination of input signals deter-
mines the number of attractors attained by the system.




4 CDK-4/CYD-1  CKI-1 
5 CDK-2/CYE-1  LIN-35 
6 LIN-12i → LIN-12m →
7 CDK-4/CYD-1  CDK-1/CYB-3 
8 SCF  APC 
9 CDK-2/CYE-1  LIN-35  EFL-1 →
10 LIN-12i  MPK-1  LIN-12m →
11 CDK-4/CYD-1  CDK-1/CYB-3 → CKI-1 
12 CDK-4/CYD-1  CDK-1/CYB-3 → APC → CKI-1 
13 SCF  APC → CKI-1  CDK-2/CYE-1 →
14 CKI-1  CDK-2/CYE-1 → LIN-12i  MPK-1 
15 CKI-1  CDK-1/CYB-3  LIN-12i  MPK-1 
16 SCF  CDK-4/CYD-1  CKI-1  CDK-1/CYB-3 → APC 
17 SCF  CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
18 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC 
19 SCF  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 → LIN-39 →
20 SCF  CDK-4/CYD-1  CDK-1/CYB-3  LIN-12i  MPK-1 →
LIN-39 →
21 SCF  APC → CKI-1  CDK-4/CYD-1  LIN-35  CDK-2/CYE-1 →
22 SCF  APC  CDK-1/CYB-3  LIN-12i  MPK-1 → LIN-39 →
23 SCF  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC 
24 CKI-1  CDK-1/CYB-3  CDK-4/CYD-1 → LIN-12m → LIN-12i 
MPK-1 
25 CKI-1  CDK-4/CYD-1  LIN-35 → CDK-2/CYE-1 → LIN-12i 
MPK-1 
26 SCF  CDK-4/CYD-1  CDK-1/CYB-3  LIN-12i  MPK-1  CKI-1 
CDK-2/CYE-1 →
27 SCF  CDK-4/CYD-1  CKI-1  CDK-2/CYE-1 → LIN-12i 
MPK-1 → LIN-39 →
28 SCF  CDK-4/CYD-1  LIN-35  CDK-2/CYE-1 → LIN-12i 
MPK-1 → LIN-39 →
29 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → CKI-1 
CDK-2/CYE-1 →
30 SCF  APC → CKI-1  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-2/CYE-1 →
31 SCF  APC → CKI-1  CDK-1/CYB-3  LIN-12i  MPK-1 →
LIN-39 →
32 SCF  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1  CKI-1 
CDK-2/CYE-1 →
33 SCF  APC  CDK-1/CYB-3  LIN-12i  MPK-1  CKI-1 
CDK-2/CYE-1 →
34 CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 
LIN-12i  MPK-1 
35 CKI-1  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 
LIN-12i  MPK-1 
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Table 1 Positive feedback loops in the network of Figure 2
(Continued)
36 SCF  CDK-4/CYD-1  CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 →
CDK-1/CYB-3 → APC 
37 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-2/CYE-1 →
LIN-12i  MPK-1 → LIN-39 →
38 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC →
CKI-1  CDK-2/CYE-1 →
39 SCF  CDK-4/CYD-1  CDK-1/CYB-3 → CKI-1  CDK-2/CYE-1 →
LIN-12i  MPK-1 → LIN-39 →
40 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1 → LIN-12m →
LIN-12i  MPK-1 → LIN-39 →
41 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-2/CYE-1 → LIN-12i 
MPK-1 → LIN-39 →
42 CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-2/CYE-1 → LIN-12i  MPK-1 
43 SCF  CDK-2/CYE-1 → LIN-12i  MPK-1  CKI-1  CDK-4/CYD-1 
CDK-1/CYB-3 → APC 
44 SCF  CDK-4/CYD-1  CDK-1/CYB-3 → APC → CKI-1 
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
45 CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 
CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 
46 SCF  APC → CKI-1  CDK-1/CYB-3  CDK-4/CYD-1 → LIN-12m →
LIN-12i  MPK-1 → LIN-39 →
47 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1 → LIN-12m → LIN-12i
 MPK-1  CKI-1  CDK-2/CYE-1 →
48 SCF  CDK-4/CYD-1  LIN-35 → CDK-2/CYE-1 → LIN-12i  MPK-1
 CKI-1  CDK-1/CYB-3 → APC 
49 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  CKI-1  CDK-2/CYE-1
→ LIN-12i  MPK-1 → LIN-39 →
50 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35  CDK-2/CYE-1
→ LIN-12i  MPK-1 → LIN-39 →
51 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-4/CYD-1 → LIN-12m →
LIN-12i  MPK-1 → LIN-39 →
52 SCF  APC  CDK-1/CYB-3  LIN-12i  MPK-1  CKI-1 
CDK-4/CYD-1  LIN-35  EFL-1 → CDK-2/CYE-1 →
53 SCF  APC → CKI-1  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-1/CYB-3  LIN-12i  MPK-1 → LIN-39 →
54 SCF  APC → CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 →
CDK-1/CYB-3  LIN-12i  MPK-1 → LIN-39 →
55 SCF  APC → CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
56 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
57 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-4/CYD-1  LIN-35 
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
58 SCF  APC → CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 
EFL-1 → CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
59 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-4/CYD-1  LIN-35 
EFL-1 → CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
60 SCF  APC → CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 →
CDK-1/CYB-3  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 →
LIN-39 →
Table 2 Negative feedback loops in the network of Figure 2
1 CDK-1/CYB-3 → APC 
2 CKI-1  CDK-1/CYB-3 →
3 SCF  CDK-2/CYE-1 →
4 CDK-4/CYD-1  CKI-1  CDK-1/CYB-3 
5 CKI-1  CDK-1/CYB-3 → APC →
6 SCF  CDK-4/CYD-1  CKI-1  CDK-2/CYE-1 →
7 LIN-12i  MPK-1 → LIN-39 → LIN-12m →
8 SCF  CDK-4/CYD-1  LIN-35  CDK-2/CYE-1 →
9 CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 
10 SCF  CDK-4/CYD-1  CDK-1/CYB-3 → APC 
11 CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 →
12 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-2/CYE-1 →
13 CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → CKI-1 
14 SCF  CDK-4/CYD-1  CDK-1/CYB-3 → CKI-1  CDK-2/CYE-1 →
15 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-2/CYE-1 →
16 CKI-1  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 
17 CKI-1  CDK-4/CYD-1  CDK-1/CYB-3  LIN-12i  MPK-1 
18 CDK-4/CYD-1  CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 →
CDK-1/CYB-3 
19 CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC →
20 CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC → CKI-1 
21 SCF  CDK-4/CYD-1  CDK-1/CYB-3 → APC → CKI-1 
CDK-2/CYE-1 →
22 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  CKI-1 
CDK-2/CYE-1 →
23 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 
CDK-2/CYE-1 →
24 CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 → CDK-2/CYE-1 →
LIN-12i  MPK-1 
25 CKI-1  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-2/CYE-1 →
LIN-12i  MPK-1 
26 SCF  CDK-2/CYE-1 → LIN-12i  MPK-1  CKI-1  CDK-1/CYB-3 →
APC 
27 SCF  CDK-4/CYD-1  CKI-1  CDK-1/CYB-3  LIN-12i  MPK-1 →
LIN-39 →
28 SCF  APC → CKI-1  CDK-2/CYE-1 → LIN-12i  MPK-1 →
LIN-39 →
29 SCF  APC → CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 
CDK-2/CYE-1 →
30 SCF  APC  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-2/CYE-1 →
31 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-4/CYD-1  LIN-35 
CDK-2/CYE-1 →
32 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3  LIN-12i 
MPK-1 → LIN-39 →
33 SCF  APC → CKI-1  CDK-4/CYD-1 → LIN-12m → LIN-12i 
MPK-1 → LIN-39 →
34 SCF  APC → CKI-1  CDK-4/CYD-1  CDK-1/CYB-3  LIN-12i 
MPK-1 → LIN-39 →
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Table 2 Negative feedback loops in the network of Figure 2
35 SCF  APC → CKI-1  CDK-1/CYB-3  CDK-4/CYD-1  LIN-35 
EFL-1 → CDK-2/CYE-1 →
36 SCF  APC  CDK-1/CYB-3 → CKI-1  CDK-4/CYD-1  LIN-35 
EFL-1 → CDK-2/CYE-1 →
37 SCF  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3  LIN-12i 
MPK-1 → LIN-39 →
38 SCF  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1  CKI-1 
CDK-1/CYB-3 → APC 
39 SCF  APC → CKI-1  CDK-4/CYD-1  LIN-35  CDK-2/CYE-1 →
LIN-12i  MPK-1 → LIN-39 →
40 SCF  APC  CDK-1/CYB-3  LIN-12i  MPK-1  CKI-1 
CDK-4/CYD-1  LIN-35 → CDK-2/CYE-1 →
41 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3  LIN-12i 
MPK-1  CKI-1  CDK-2/CYE-1 →
42 SCF  CDK-2/CYE-1 → LIN-12i  MPK-1  CKI-1  CDK-4/CYD-1 
LIN-35  EFL-1 → CDK-1/CYB-3 → APC 
43 SCF  CDK-4/CYD-1  CKI-1  CDK-2/CYE-1  LIN-35  EFL-1 →
CDK-1/CYB-3  LIN-12i  MPK-1 → LIN-39 →
44 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-2/CYE-1 → LIN-12i 
MPK-1  CKI-1  CDK-1/CYB-3 → APC 
45 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → CKI-1 
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
46 SCF  APC → CKI-1  CDK-4/CYD-1  LIN-35  EFL-1 →
CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
47 SCF  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 
CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 → LIN-39 →
48 SCF  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1  CKI-1 
CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC 
49 SCF  CDK-4/CYD-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC →
CKI-1  CDK-2/CYE-1 → LIN-12i  MPK-1 → LIN-39 →
50 SCF  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 → CKI-1 
CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 → LIN-39 →
51 SCF  CDK-2/CYE-1  LIN-35  EFL-1 → CDK-1/CYB-3 → APC →
CKI-1  CDK-4/CYD-1 → LIN-12m → LIN-12i  MPK-1 → LIN-39 →
Redundancy among feedback circuits is emerging as a
generic trait of regulatory networks. Furthermore, feed-
back circuit redundancy could play an important role in
network robustness to mutations and noise [76].
Conclusions
Our model recovers the stable patterns of activation of
the considered molecular components under wild type
andmutant conditions, replicating those patterns encoun-
tered on actual cells during vulval development in C.
elegans. To the best of our knowledge, the present model
is the first that explores the dynamic effect of the mech-
anism for the cross-regulation between the cell cycle and
the cell fate determination of vulval cells, mechanism that
was proposed by [42] and [77]. Our model provides a suit-
able approach to understand the coordinated regulation
of cell-cycle progression and differentiation during this
process.
The cross-regulation between cell differentiation and
cell-cycle progression in vulval cells of C. elegans is medi-
ated by the activation of SCF by LIN-39, the inhibition
of CKI-1 by MPK-1, the inhibition of LIN-12i by CDK-
1/CYB-3, the activation of LIN-12i by CDK-2/CYE-1, and
the activation of LIN-12m by CDK-4/CYD-1. The type
of regulatory interactions that grant such dynamic coor-
dination might be conserved in other biological systems
[78,79], and may also constitute a useful framework to
address such coordination in other systems.
Our modeling effort resulted in the following predic-
tions for the system under study: a) the activation of
SCF by LIN-39, removing this interaction causes cell
cycle quiescence in our model. b) the activation of CDK-
1/CYB-3 by EFL-1, removing this interaction causes an
endoreplication-like cell cycle. c) the inhibition of CDK-
4/CYD-1 by CKI-1, removing this interaction causes a
short cell cycle. d) the inhibition of CDK-1/CYB-3 by CKI-
1, removing this interaction does not change the dynamic
behavior of our model, e) the inhibition of CDK-1/CYB-
3 by CDK-4/CYD-1, removing this interaction causes a
modified cell cycle. f ) the inhibition of CDK-4/CYD-1 by
CDK-1/CYB-3, removing this interaction causes a short
cell cycle.
Given the importance of the Notch signaling pathway
for different developmental processes, it is fundamen-
tal to understand how it interacts with other signaling
pathways. Here, we highlight the temporal regulation of
LIN-12 by different CDK/cyclin complexes, which leads
to precise spatio-temporal regulation of Notch signaling
during vulva development and opens a wide range of
possibilities in the comprehension of how cell fates are
established under a specific combination of intracellular
and extracellular signals. Our model shows that regula-
tion of Notch signaling by the cell cycle preserves the
potential of the VPCs and the three fates to differentiate
and de-differentiate, allowing them to remain completely
responsive to the concentration of LIN-3 and LS in the
extracellular micro-environment.
Another important contribution of our model is that
the need for a sequential control of fate determination
disappears completely. Without the cell cycle effect, in a
microenvironment with a moderately high level of LIN-
3 and LS, a VPC would acquire either the primary or
the secondary fate, depending on which inductive signal
affected the cell first. In our model, however, the VPC
will always acquire the secondary fate. Dynamical analysis
such as ours are needed to achieve an adequate under-
standing of molecular regulation during the development
of multicellular organisms.
Certain mutations can dramatically affect the behavior
of a regulatory network, even if they do not cause the loss
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of all the functions of a protein. Simulating the removal
of certain interactions, we were able to propose some
changes to specific regions of certain proteins that could
lead to abnormal vulval development in C. elegans.
Despite the broad agreement between our model and
the experimental data, there is ample room for improve-
ment. Specifically, we will try to incorporate in future
versions the molecular mechanism involved when the cell
cycle is activated or inactivated by a combination of CKI-1
activation by LIN-29 during L4 and SCF mediated degra-
dation of CDC-25.1, as well as the molecules involved in
the transitions between mitosis, meiosis, endoreplication
and the embryonic cell cycle.
Methods
Molecular basis of the regulatory network
We built a simplified model of the molecular network
involved in the fate determination of the VPCs and the
control of the cell cycle by connecting two functional
modules, that is, sets of biological molecules that are
involved in accomplishing a specific biological function
in the cell. Specifically, we used one module for the net-
work of molecules involved in cell cycle control and a
second module for the network of molecules involved in
the control of vulval fate determination. We built the two
functional modules by including only the molecules with
very penetrant mutant phenotypes reported in the liter-
ature. For the fate determination module, we included
only the ligands and the effectors of the Ras and Notch
signaling cascades, and MPK-1, necessary to represent
the mutual inhibition between them. For the cell cycle
module, we included only the three main CDK/Cyclin
complexes and their main regulators. Most interactions in
the model are supported by experimental evidence in C.
elegans, as summarized below. These interactions can be
classified as activations or inhibitions [80], defined as fol-
lows: Given two genes i and j, i activates j if there exists a
configuration (i.e. a pattern of molecular activation) x =
(x1, . . . , xn) and values a and b, with a > b, such that:
fj(x1, . . . , xi−1, a, xi+1, . . . , xn)
− fj(x1, . . . , xi−1, b, xi+1, . . . , xn) > 0
Conversely, i inhibits j if there exists a configuration x =
(x1, . . . , xn) and values a and b, with a > b, such that:
fj(x1, . . . , xi−1, a, xi+1, . . . , xn)
− fj(x1, . . . , xi−1, b, xi+1, . . . , xn) < 0
According to this definition, it is possible for gene i to
both activate and inhibit gene j. In this case, we say that
the rule or interaction is ambiguous. The only ambigu-
ous update rule in our model is in LIN-12i (Equation 6).
The model also contains interactions reported in other
organisms, namely, the mutual inhibition between APC
and SCF in mammals, the activation of CKI-1 by APC
in humans, the activation of CKI-1 by CDK-1/CYB-3 in
yeast, and the inhibition of LIN-35 by CDK-2/CYE-1 in
mammals. Finally, the model also includes interactions
that are predictions of our model, namely, the mutual
inhibition between CDK-1/CYB-3 and CDK-4/CYD-1,
the activation of CDK-1/CYB-3 by EFL-1, the inhibition
of CDK-4/CYD-1 and CDK-1/CYB-3 by CKI-1, and the
activation of SCF by LIN-39.
Molecules involved in VPC fate determination:
The Ras/MAPK signaling cascade is represented by three
nodes, LIN-3, MPK-1, and LIN-39. LIN-3 is an EGF
ortholog, and functions as an external signal that is used as
a parameter that does not change during each simulation.
LIN-3 activates the Ras/MAPK signaling [16,29,81,82],
whose main effector is MPK-1 [83,84], an ERK ortholog.
MPK-1 phosphorylates many important transcription fac-
tors, such as LIN-39, LIN-1, LIN-31 and some compo-
nents of the mediator complex like LIN-25 and SUR-
2, that bind to the promoters of lin-39, activating its
transcription. The LIN-39 product, is a HOM-C protein
homologous to Deformed and Sex combs reduced. Impor-
tantly, phosphorylated LIN-39 activates its own expres-
sion [68,83-85].
To represent the Notch signaling cascade we included
in the simplified model the lateral signal as well as the
ortholog of Notch lin-12. The lateral signal (LS) func-
tions as a parameter of the model, and it comprises DSL-1
and LAG-2 or APX-1. DSL-1 originates from P6.p and
forms a gradient, while LAG-2 and APX-1 are membrane
proteins that are also expressed by P6.p, whose effect is
on the neighbor cells that are in direct physical contact,
that is, P5.p and P7.p [86]. LIN-12 is represented by two
nodes in our model. On the one hand, LIN-12i repre-
sents the fragment of LIN-12 that travels to the nucleus
and forms part of the LIN-12intra/LAG-1/SEL-8 complex.
This complex activates the transcription of the lateral
signal targets, such as lin-11, lip-1 and lin-12 [87], and
stabilizes the membrane localization of LIN-12 through
mir-61 and VAV-1 [88]. On the other hand, LIN-12m
represents the protein localized in the membrane, func-
tioning as a receptor for the lateral signal [89,90]. Finally,
it is known that LIN-39 activates the transcription of
lin-12 [91].
We included the interactions that allow for a mutual
inhibition of the Ras and Notch pathways. MPK-1
activates the mediator complex, increasing the rate at
which LIN-12 is removed from the membrane and
marked for degradation [92,93]. Now, LIP-1 inactivates
MPK-1 [94], and ARK-1 inhibits LET-23 in a SEM-
5-dependent mechanism [95]. Both LIP-1 and ARK-1
are lateral signal targets, and are activated by LIN-12i.
Thus, there is a net negative effect from LIN-12i to
MPK-1.
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Molecules involved in the control of the cell cycle and their
interactions:
In general, the molecular mechanism for the control of the
cell cycle is based on the activity of a cyclin-dependent
kinase (CDK), which is required to advance from one stage
of the cell cycle to the next.
Each CDK binds to certain cyclins when they are avail-
able; specifically those that have a high enough binding
affinity with the CDK. CDK-inhibitory proteins (CKIs)
associate with Cyclin/CDK complexes to keep them inac-
tive, and phosphorylation by Wee1/Myt1 kinases also
inhibits their activity. Cyclin/CDK activation requires
phosphorylation, ubiquitination and proteolysis of the
CKI, phosphorylation of the CDK by a CDK-activating
kinase (CAK), as well as the removal of the inhibitory
phosphates by a Cdc25 phosphatase. Cyclin destruction
leads to inactivation. Ubiquitination and proteolysis of cell
cycle regulators in late G1 and S requires cullin-based E3
ligases such as Skp1-Cul1-F box (SCF), while in M phase
and early G1 the activity of the anaphase-promoting com-
plex (APC) –which is an E3 RING ubiquitin ligase– is
needed [69].
In C. elegans, the regulatory function of three
CDK/Cyclin complexes during the cell cycle is known:
CDK-4/CYD-1 is the first complex involved in the control
of the G1 to S transition, and the expression of cdk-4 and
cyd-1 is sufficient to activate the expression the S phase
marker rnr::GFP [96]. CYD-1 is likely to be degraded by
SCF [97], and CDK-4/CYD-1 may be a target of CKI-1
inhibition because CKI-1 binds CYD-1 [98]. CDK-2/CYE-
1 is the second complex involved in the control of the
G1 to S transition, CDK-2 binds to CYE-1 and CKI-1
may inhibit CYE-1 function [69,98]. When CKI-1 is ubiq-
uitinated, it dissociates from CDK-2/CYE-1, then CDK-
2/CYE-1 activity allows the progression from G1 to S [69].
The promoter of cye-1 contains potential EFL-1/DPL-1
binding sites [99]. CUL-1 (part of SCF) may inhibit CYE-
1, and CDK-1/CYB-3 is involved in the G2 toM transition
but not G1 to S [69]. CDK-1 binds to CYB-1 and CYB-3
in vitro, and APC-11 inhibits CYB-1 [100]. CDK-1/CYB-
3 activates CDC-25.1 and it inhibits WEE-1.3 [63,69,101],
thus forming two positive self regulation cycles that we
include in our model without explicitly incorporating the
nodes for simplicity.
Two CKIs exist in C. elegans, namely, cki-1 and cki-2.
Both are known to regulate the cell cycle, but we only
included cki-1 in the model for simplicity, and because
many of the most penetrant phenotypes are the result of
mutations affecting both genes [102]. The gene cki-1 is
orthologous to the mammalian cyclin-dependent kinase
inhibitor p27/KIP1 and cki-1 is required to stop the cell
cycle and to stay at the G0/G1 phase. The protein CKI-1 is
one of the main regulators of the postembryonic cell cycle
in C. elegans [103]. In humans, the ortholog of FZR-1,
which is a regulatory subunit of APC indirectly promotes
the accumulation of the ortholog of CKI-1 [65,69]. Addi-
tionally, in yeast the ortholog of CDK-1/CYB-3 activates
the ortholog of CDC-14 [65,66], then CDC-14 upregu-
lates the accumulation of CKI-1 [65,104]. Finally, CKI-1
is negatively regulated by CDK-4/CYD-1; the evidence
supporting this interaction is that CKI-1 binds to CDK-
4/CYD-1 and loss of cki-1/2 function rescues multiple
aspects of the cyd-1 loss of function (lf ) and cdk-4(lf )
mutant phenotypes [100].
The protein EFL-1 is a homolog of mammalian E2F,
which inhibits the G1-to-S transition. In mammals, Rb
binds to E2F, inhibiting its function as an activating tran-
scription factor. It is worth noting that EFL-1 may need
DPL-1 as a co-factor [69]. The protein LIN-35 is orthol-
ogous to Rb, CDK-4/CYD-1 negatively regulates LIN-35
activity [100,105], and inmammals, the orthologs of CDK-
2 and CYE-1 are needed to fully inhibit the Rb function
[105,106].
In C. elegans, the components of the SCF complex
include the Skp1-like proteins SKR-1 and SKR-2 [97],
LIN-23 (F-box), and CUL-1 [71,107,108]. The compo-
nents of APC include MAT-1, MAT-2, MAT-3, CDC-
26, APC-2, APC-10, APC-11, APC-17, EMB-1(APC16),
EMB-27, EMB-30, and FZR-1 [97,109]. Furthermore,
mammalian Cdk1 activates APC/C [110], while APC and
SCF inhibit each other [110-112].
CDK-7 is a CAK ortholog, which likely associates
with the cyclin CYH-1 [100], but the function of these
molecules in the regulation of the cell cycle in C. elegans
is not known because most cdk-7 mutations are lethal. C.
elegans, has twoWEE-1 homologues, namely, wee-1.1 and
wee-1.3, which are active in the germ line [101,113]. There
are also four CDC-25 homologues: cdc-25.1, cdc-25.2, cdc-
25.3, and cdc-25.4. Of these four, only the function of
CDC-25.1 as a cell cycle regulator is known [101].
Interactions between themolecules involved in the control of
the cell cycle and themolecules involved in the control of VPC
fate determination:
LIN-3/EGF activates Ras signaling. Now, LIN-1 and LIN-
31—effectors of Ras—as well as the Mediator complex
are necessary for cell cycle quiescence. Specifically, when
Ras is active, LIN-1 and LIN-31 do not activate the tran-
scription of CKI-1, and we included this regulation as
an inhibition of CKI-1 by MPK-1 [77]. Moreover, LIN-1,
LIN-31 and the Mediator complex activate lin-39 tran-
scription [68,85] and LIN-39 is required for the divisions
of the VPCs [114]. Additionally, the three CDK/Cyclin
complexes that regulate the cell cycle also regulate Notch
signaling. In particular, the CDK-4/CYD-1 complex stabi-
lizes the location of LIN-12 (NOTCH) on the cell mem-
brane; the CDK-2/CYE-1 complex inhibits the proteolysis
of the fragment of LIN-12 that functions as a transcription
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factor in the nucleus; and the CDK-1/CYB-3 complex acti-
vates the expulsion from the nucleus and the degradation
of the LIN-12 fragment [42].
The regulatory network as a dynamical system
We first reconstructed the cell cycle functional module
from an expected time series with the use of BoolNet
[115]. BoolNet produced a probabilistic Boolean network
with several possible update rules for each node.We chose
for each node the rule that best reflected the biological
knowledge, and made a few modifications. Specifically,
we included the mutual inhibition between APC and
SCF, which does not change the dynamic of the wild
type model, but changes the simulated effect of several
mutations.
Next, we developed a deterministic discrete dynamical
model by building the VPC fate determination module,
and then connecting it with the cell cycle module. In
our model there is one node with four possible levels
of activation—LIN-3—. This characteristic is necessary
because a) the VPCs P3.p, P8.p and P9.p, which acquire
the tertiary fate, have no Ras activity (i.e. a level of 0),
b) the VPCs P5.p and P7.p usually have a moderate level
of Ras signaling which is sufficient to determine the sec-
ondary fate (i.e. a level of 1), c) P6.p is characterized by
a high level of Ras signaling (i.e. a level of 2), which is
sufficient to determine the primary fate, but only in the
absence of negative regulation, and d) in some experi-
ments with worms that have two or more anchor cells,
the level of Ras signaling is high enough to overcome the
effects of the negative regulators (i.e. a level of 3).
Two nodes of the network needed to be modeled as
components with three levels of activation—MPK-1 and
LIN-39—, which are at the end of the Ras signaling cas-
cade, or downstream from it. They have no inhibitors
to overcome, and hence only the levels 0, 1, and 2 are
considered.
The rest of the nodes in the network were considered
as Boolean, since the experimental evidence report either
a full gain or total loss of function. Therefore, the rules
determining the state of activation of each node as a
function of their regulatory inputs are as follows:
LIN-3(t + 1) = LIN-3(t) (1)
MPK-1(t + 1) =
⎧⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎩
2 if (LIN-3(t) = 3 and MPK-1(t) > 0) or
(LIN-3(t) = 2 and LIN-12i(t) = 0 and
MPK-1(t) > 0)
0 if MPK-1(t) < 2 and




LIN-39(t + 1) =
{ 2 if MPK-1(t) = 2 and LIN-39(t) > 0
0 When simulating lin-39 loss of function
1 otherwise
(3)
LS(t + 1) = LS(t) (4)
LIN-12m(t + 1) =
⎧⎨
⎩
1 if (LIN-39(t) > 0 or LIN-12i(t) = 1) and
(MPK-1(t) ≤ 1 or CDK-4/CYD-1(t) = 1)
0 otherwise
(5)
LIN-12i(t + 1) =
⎧⎪⎪⎨
⎪⎪⎩
1 if (LS(t) = 1 and LIN-12m(t) = 1) or
((LIN-12i(t) = 1or LIN-3(t) = 1) and




CKI-1(t + 1) =
⎧⎪⎨
⎪⎩
1 if (MPK-1(t) = 0) and
(CDK-4/CYD-1(t) = 0 and APC(t) = 1
or CDK-1/CYB-3(t) = 1))
0 otherwise
(7)
EFL-1(t + 1) =
{
1 if LIN-35(t) = 0
0 otherwise (8)
LIN-35(t + 1) =
⎧⎨
⎩







1 if LIN-39(t) > 0 and APC(t) = 0





1 if SCF(t) = 0 and CDK-1/CYB-3(t) = 1
0 otherwise
(11)
CDK-4/CYD-1(t + 1) =
{ 1 if CKI-1(t) = 0 and SCF(t) = 0
and CDK-1/CYB-3(t) = 0
0 otherwise
(12)
CDK-2/CYE-1(t + 1) =
{ 1 if EFL-1(t) = 1 and LIN-35(t) = 0
and CKI-1(t) = 0 and SCF(t) = 0
0 otherwise
(13)
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CDK-1/CYB-3(t + 1) =
⎧⎪⎪⎨
⎪⎪⎩
1 if CKI-1(t) = 0 and APC(t) = 0
and EFL-1(t) = 1
and (CDK-4/CYD-1(t) = 0
or CDK-1/CYB-3(t) = 1)
0 otherwise
(14)
Subsequently, we used the software packageGriffin [73],
to find the interactions that are necessary to recover a
cyclic attractor that visits the configurations characteris-
tic of each cell-cycle phase in the temporal sequence that
is observed in actual cells. Additionally, we specified that
all the interaction signs must be unambiguous.
Finally, we used the SQUADmethodology [116] to build
a deterministic continuous version of the cell cycle mod-
ule, based on the Boolean update rules that we obtained
based on an expected time series with the use of Bool-
Net. We used the continuous version of the module to
verify that the cyclic behavior of the network is not an
artifact of the synchronous updating of the discrete model
[63]. The differential equations describing the continuous
model are as follows:
squad(Xi,ωi) = −e
0.5h + e−h(ωi−0.5)
(1 − e0.5h)(1 + eh(ωi−0.5)) − γiXi (15)
h = 10 (16)
γi = 0.95 (17)
ωCKI−1 = min((1 − CDK-4/CYD-1),max(APC, CDK-1/CYB-3))
(18)
d(CKI-1)
dt = squad(CKI-1, ωCKI−1) (19)
ωEFL−1 = 1 − LIN-35 (20)
d(EFL-1)
dt = squad(EFL-1, ωEFL−1) (21)
ωLIN−35 = min(1 − CDK-4/CYD-1, 1 − CDK-2/CYE-1))
(22)
d(LIN-35)
dt = squad(LIN-35, ωLIN−35) (23)
ωSCF = min(1 − APC, CDK-2/CYE-1)) (24)
d(SCF)
dt = squad(SCF, ωSCF) (25)
ωAPC = min(1 − SCF, CDK-1/CYB-3)) (26)
d(APC)
dt = squad(APC, ωAPC) (27)
ωCDK−4/CYD−1 = min(1 − CKI-1, 1 − SCF, 1 − CDK-1/CYB-3)
(28)
d(CDK-4/CYD-1)
dt = squad(CDK-4/CYD-1, ωCDK−4/CYD−1)
(29)
ωCDK−2/CYE−1 = min(EFL-1, 1 − LIN-35, 1 − CKI-1, 1 − SCF)
(30)
d(CDK-2/CYE-1)
dt = squad(CDK-2/CYE-1, ωCDK−2/CYE−1)
(31)
ωCDK−1/CYB−3 = min(1 − CKI-1, 1 − APC, EFL-1,
max(1 − CDK-4/CYD-1, CDK-1/CYB-3)) (32)
d(CDK-1/CYB-3)
dt = squad(CDK-1/CYB-3, ωCDK−1/CYB−3)
(33)
Endnote
aGriffin is a symbolic computational tool under
development that uses a SAT solver to find Boolean
networks satisfying certain constraints, for example, the
existence of known or hypothetical interactions.
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